CD274 and autoimmune disease: In addition, another percent of patients, despite being carriers of PDL-1 positive tumors, has clear and obvious contraindications to the use of immunotherapy, as for example occurs for patients with autoimmune diseases or for patients with chronic viral hepatitis (from virus B or C).